patisiran sodium

Spain

Drugs containing this active substance

  • ONPATTRO 2 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION

    It is used to treat a hereditary disease called hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis), which is caused by problems with a protein called transthyretin (TTR). The medication helps reduce the amount of this protein produced by the liver to decrease the effects of the disease.

    Form: solution for infusion, concentrate

    Active substance Dosage
    patisiran sodium 10,5 mg

    ATC: N07X N07XX N07XX12

    Manufacturer: Alnylam Netherlands B.V.